Mehdi Gasmi Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mehdi Gasmi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Mehdi Gasmi for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 173,000 | |
Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 16.23 | 5,000 | 81,156 | 258,979 | 264 K to 259 K (-1.89 %) |
Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 263,979 | 259 K to 264 K (+1.93 %) |
Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 10,000 | 48,000 | 178,000 | |
Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 15.07 | 10,000 | 150,690 | 258,979 | 269 K to 259 K (-3.72 %) |
Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 10,000 | 48,000 | 268,979 | 259 K to 269 K (+3.86 %) |
Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 15.05 | 15,494 | 233,185 | 258,979 | 274.5 K to 259 K (-5.64 %) |
Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 11.33 | 31,451 | 356,340 | 289,967 | 321.4 K to 290 K (-9.79 %) |
Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Grant | A | 0.00 | 88,496 | 0 | 321,418 | 232.9 K to 321.4 K (+37.99 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 10.24 | 11,551 | 118,282 | 309,867 | 321.4 K to 309.9 K (-3.59 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 5.98 | 589 | 3,522 | 321,418 | 322 K to 321.4 K (-0.18 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.55 | 10,652 | 37,815 | 322,007 | 332.7 K to 322 K (-3.20 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.33 | 12,599 | 41,955 | 332,659 | 345.3 K to 332.7 K (-3.65 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 6.30 | 605 | 3,812 | 247,762 | 248.4 K to 247.8 K (-0.24 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 6.85 | 10,806 | 74,021 | 248,367 | 259.2 K to 248.4 K (-4.17 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 7.05 | 11,433 | 80,603 | 259,173 | 270.6 K to 259.2 K (-4.22 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 2.50 | 5,479 | 13,698 | 270,606 | 276.1 K to 270.6 K (-1.98 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 2.70 | 657 | 1,774 | 276,085 | 276.7 K to 276.1 K (-0.24 %) |
Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.00 | 12,793 | 38,379 | 276,742 | 289.5 K to 276.7 K (-4.42 %) |